Market closed

PharmaCyte Biotech/$PMCB

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About PharmaCyte Biotech

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Ticker

$PMCB
Trading on

Industry

Biotechnology

Employees

2

ISIN

US71715X2036

PMCB Metrics

BasicAdvanced
$7.8M
0.88
$1.29
-0.53
-
$7.8M
-0.53
$1.84
$1.03
15K
14.203
14.029
-4.89%
42.89%
0.88
0.2
0.2
-3.867
-204.34%
53.11%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PMCB

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for PharmaCyte Biotech stock?

What is the P/E ratio for PharmaCyte Biotech stock?

Does PharmaCyte Biotech stock pay dividends?

When is the next PharmaCyte Biotech dividend payment date?

What is the beta indicator for PharmaCyte Biotech?